It is primarily prescribed to help individuals with type 2 diabetes manage their blood sugar levels
In comparison, the STEP-1 trial reported that 2.4mg/weekly semaglutide led to side effects in 89.7% of the subjects, with the most common complaints being [17]: Nausea (44.2% of subjects) Diarrhea (31.5%) Vomiting (24.8%) Constipation (23.4%) Dyspepsia (10.3%) Abdominal pain (10% Gallbladder-related events (2.6%) The majority of gastrointestinal reactions were of mild to moderate intensity, temporary, and resolved without needing a permanent halt in treatment
That is where logging can help
By then, the real-world safety data will be richer, NICE will have made an access decision, and pricing and supply will be clearer
Are low glutathione levels a disease
It is essential to be aware of these potential side effects and seek medical advice from your healthcare professional if you notice any concerning symptoms